Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
2019 · Journal of Hematology & Oncology · 859 citations
https://doi.org/10.1186/s13045-019-0770-1
T
Tongyan Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
82
Papers
2.9K
Citations
20
h-index
35
i10-index
Tongyan Liu is an academic researcher from Peking University. The author has contributed to research in topics: RNA modifications and cancer & Lung Cancer Treatments and Mutations & Cancer-related molecular mechanisms research. The author has an h-index of 20, co-authored 70 publications.
ORCID: 0000-0001-5677-4513Papers by this author
worksMIR99AHG is a noncoding tumor suppressor gene in lung adenocarcinoma
2021 · Cell Death and Disease · 43 citations
https://doi.org/10.1038/s41419-021-03715-7
Long non-coding RNAs in lung cancer: implications for lineage plasticity-mediated TKI resistance
2020 · Cellular and Molecular Life Sciences · 19 citations
https://doi.org/10.1007/s00018-020-03691-9
RASON promotes KRASG12C-driven tumor progression and immune evasion in non-small cell lung cancer
2025 · Journal of Experimental & Clinical Cancer Research · 7 citations
https://doi.org/10.1186/s13046-025-03369-9
Persist or resist: Immune checkpoint inhibitors in <scp><i>EGFR</i></scp>‐mutated <scp>NSCLC</scp>
2024 · Cancer Science · 4 citations
https://doi.org/10.1111/cas.16428
Targeting LINC01711 in FAP+ cancer-associated fibroblasts overcomes lactate-mediated immunosuppression and enhances anti-PD-1 efficacy in lung adenocarcinoma
2025 · Cell Death and Disease · 3 citations
https://doi.org/10.1038/s41419-025-07974-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat